Etanercept (TNF receptor fusion protein, enbrelR) is effective and well tolerated in active refractory Crohn's disease: results of a single center pilot trial
Authors:
D'Haens, G × Geboes, Karel Noman, M Lemmens, L Rugeerts, P #
Issue Date:
2000
Publisher:
Editrice gastroenterologica italiana
Host Document:
Digestive and Liver Disease vol:32 issue:suppl. 1 pages:42